qPCR
Oxford, Sanger Institute Researchers Draw on Gene Expression Testing for Sepsis Risk Algorithm
Premium
The algorithm distinguishes between groups of patients who are at high risk of developing severe illness and those who are low risk.
SkylineDx Gains CE-IVD Mark for Melanoma Metastasis Risk Assay
The Netherlands-based firm is partnering with Belgian company Biocartis on European commercialization of the qPCR assay, which could reduce unnecessary surgeries.
Harvard University, Wyss Institute License Protein Detection Technology to Spear Bio
Spear Bio plans to use the technology to build a protein detection platform and an assay that can measure levels of neutralizing antibodies against SARS-CoV-2.
GenDx Licenses cfDNA Assay for Rejection Monitoring From Medical College of Wisconsin
The method allows for less invasive and more economical post-transplant monitoring and could also be adapted for other organ applications.
The new tests, once developed, will be used for selecting patients who might best benefit from therapies for kidney disease, nonalcoholic steatohepatitis, and respiratory disease.